Alterations in microRNA expression profile in HCV-infected hepatoma cells: Involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway

Biochemical and Biophysical Research Communications

Volumn 412, Issue 1, 2011, Pages 92-97

  Ishida, Hisashi ^a   Tatsumi, Tomohide ^a   Hosui, Atsushi ^a   Nawa, Takatoshi ^a   Kodama, Takahiro ^a   Shimizu, Satoshi ^a   Hikita, Hayato ^a   Hiramatsu, Naoki ^a   Kanto, Tatsuya ^a   Hayashi, Norio ^b   Takehara, Tetsuo ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANSAI ROSAI HOSPITAL   (Japan)

Author keywords

Hepatitis C virus; MicroRNA; PI3 kinase Akt pathway

Indexed keywords

BETA ACTIN; MICRORNA; MICRORNA 192; MICRORNA 194; MICRORNA 215; MICRORNA 320; MICRORNA 491; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MICRORNAS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 80051781560     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.07.049     Document Type: Article

References (25)

1. Seeff L.B. Natural history of hepatitis C. Hepatology 1997, 26:21S-28S.
2. Fried M.W., Shiffman M.L., Reddy K.R., Smith C., Marinos G., Goncales F.L., Haussinger D., Diago M., Carosi G., Dhumeaux D., Craxi A., Lin A., Hoffman J., Yu J. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 2002, 347:975-982.
3. Hadziyannis S.J., Sette H., Morgan T.R., Balan V., Diago M., Marcellin P., Ramadori G., Bodenheimer H., Bernstein D., Rizzetto M., Zeuzem S., Pockros P.J., Lin A., Ackrill A.M. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann. Intern. Med. 2004, 140:346-355.
4. Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294:853-858.
5. Jopling C.L., Yi M., Lancaster A.M., Lemon S.M., Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 2005, 309:1577-1581.
6. Pedersen I.M., Cheng G., Wieland S., Volinia S., Croce C.M., Chisari F.V., David M. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007, 449:919-922.
7. Banaudha K., Kaliszewski M., Korolnek T., Florea L., Yeung M.L., Jeang K.T., Kumar A. MicroRNA silencing of tumor suppressor DLC-1 promotes efficient hepatitis C virus replication in primary human hepatocytes. Hepatology 2011, 53:53-61.
8. Ishida H., Ohkawa K., Hosui A., Hiramatsu N., Kanto T., Ueda K., Takehara T., Hayashi N. Involvement of p38 signaling pathway in interferon-alpha-mediated antiviral activity toward hepatitis C virus. Biochem. Biophys. Res. Commun. 2004, 321:722-727.
9. Wang T.H., Rijnbrand R.C., Lemon S.M. Core protein-coding sequence but not core protein modulates the efficiency of cap-independent translation directed by the internal ribosome entry site of hepatitis C virus. J. Virol. 2000, 74:11347-11358.
10. Yi M., Ma Y., Yates J., Lemon S.M. Compensatory mutations in E1 p7 NS2 and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J. Virol. 2007, 81:629-638.
11. Ishida H., Li K., Yi M., Lemon S.M. p21-activated kinase 1 is activated through the mammalian target of rapamycin/p70 S6 kinase pathway and regulates the replication of hepatitis C virus in human hepatoma cells. J. Biol. Chem. 2007, 282:11836-11848.
12. Braun C.J., Zhang X., Savelyeva I., Wolff S., Moll U.M., Schepeler T., Orntoft T.F., Andersen C.L., Dobbelstein M. p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. Cancer Res. 2008, 68:10094-10104.
13. Georges S.A., Biery M.C., Kim S.Y., Schelter J.M., Guo J., Chang A.N., Jackson A.L., Carleton M.O., Linsley P.S., Cleary M.A., Chau B.N. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs miR-192 and miR-215. Cancer Res. 2008, 68:10105-10112.
14. Honda M., Kaneko S., Matsushita E., Kobayashi K., Abell G.A., Lemon S.M. Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation. Gastroenterology 2000, 118:152-162.
15. Murata T., Hijikata M., Shimotohno K. Enhancement of internal ribosome entry site-mediated translation and replication of hepatitis C virus by PD98059. Virology 2005, 340:105-115.
16. Murata T., Ohshima T., Yamaji M., Hosaka M., Miyanari Y., Hijikata M., Shimotohno K. Suppression of hepatitis C virus replicon by TGF-beta. Virology 2005, 331:407-417.
17. Barad O., Meiri E., Avniel A., Aharonov R., Barzilai A., Bentwich I., Einav U., Gilad S., Hurban P., Karov Y., Lobenhofer E.K., Sharon E., Shiboleth Y.M., Shtutman M., Bentwich Z., Einat P. MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues. Genome Res. 2004, 14:2486-2494.
18. Anzola M., Burgos J.J. Hepatocellular carcinoma: molecular interactions between hepatitis C virus and p53 in hepatocarcinogenesis. Expert Rev. Mol. Med. 2003, 5:1-16.
19. Duan H., Jiang Y., Zhang H., Wu Y. MiR-320 and miR-494 affect cell cycles of primary murine bronchial epithelial cells exposed to benzo[a]pyrene. Toxicol. In Vitro 2010, 24:928-935.
20. Schaar D.G., Medina D.J., Moore D.F., Strair R.K., Ting Y. miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation. Exp. Hematol. 2009, 37:245-255.
21. Wang X.H., Qian R.Z., Zhang W., Chen S.F., Jin H.M., Hu R.M. MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin. Exp. Pharmacol. Physiol. 2009, 36:181-188.
22. Chen L., Yan H.X., Yang W., Hu L., Yu L.X., Liu Q., Li L., Huang D.D., Ding J., Shen F., Zhou W.P., Wu M.C., Wang H.Y. The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. J. Hepatol. 2009, 50:358-369.
23. Nakano H., Miyazawa T., Kinoshita K., Yamada Y., Yoshida T. Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-X(L) in colorectal cancer cells. Int. J. Cancer 2010, 127:1072-1080.
24. Takehara T., Liu X., Fujimoto J., Friedman S.L., Takahashi H. Expression and role of Bcl-xL in human hepatocellular carcinomas. Hepatology 2001, 34:55-61.
25. Ura S., Honda M., Yamashita T., Ueda T., Takatori H., Nishino R., Sunakozaka H., Sakai Y., Horimoto K., Kaneko S. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 2009, 49:1098-1112.